
Microphyt
Develops unique solutions to industrialize the production of biomass of species of microalgae of economic interest.
- dt and ls
- biotechnology
- horizon europe
- sustainable development goals
- biotech and pharma
- climate tech
- radar de l'innovation
- observatoire industrial tech
- observatoire greentech
- bluetech
- observatoire deeptech
- blue economy
- nutrition
- alternative protein
- farming
- algae
- greentech
- food as medicine
- natural resources
- energy and greentech
- aquaculture
- participations bpifrance
- primary production
- enabler of alternative proteins
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor investor investor investor investor investor | €0.0 | round | |
* | €15.0m Valuation: €143m 199.2x EV/Revenue -75.3x EV/EBITDA | Series B | |
Total Funding | 000k |
EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2023 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | 19 % | (52 %) | 252 % | 11 % | (20 %) | 230 % | - |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | (193 %) | (392 %) | (110 %) | (384 %) | (1190 %) | (265 %) | - |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | (114 %) | (221 %) | 19 % | (399 %) | (1123 %) | (454 %) | - |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Dealroom estimates
Related Content
Notes (0)
More about Microphyt
EditMade with AI
Microphyt is a biotechnology company that develops, produces, and markets natural ingredients derived from microalgae. The company leverages a proprietary and patented photobioreactor technology that allows for the controlled and sustainable production of a wide variety of microalgae species.
Their primary market is the nutrition and wellness sector, providing ingredients for dietary supplements, functional foods, and cosmetics. The company
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.